- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/10 - Thiophene
Patent holdings for IPC class C07D 333/10
Total number of patents in this class: 184
10-year publication summary
|
13
|
11
|
8
|
11
|
5
|
8
|
7
|
8
|
9
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2253 |
7 |
| Sumitomo Chemical Company, Limited | 9057 |
5 |
| Avoscience, LLC | 12 |
5 |
| Autophagysciences, Inc | 6 |
5 |
| Korea Institute of Science and Technology | 2188 |
4 |
| Texas Heart Institute | 109 |
4 |
| Bristol-myers Squibb Company | 4817 |
3 |
| The Regents of the University of California | 20473 |
3 |
| The Johns Hopkins University | 5796 |
3 |
| Richter Life Science Development AB | 9 |
3 |
| Daegu-gyeongbuk Medical Innovation Foundation | 109 |
3 |
| F. Hoffmann-La Roche AG | 7874 |
2 |
| Agency for Science, Technology and Research | 3682 |
2 |
| Board of Regents of The Nevada System of Higher Education, on Behalf of The University of Nevada, Reno | 132 |
2 |
| CHDI Foundation, Inc. | 105 |
2 |
| Chinese PLA General Hospital | 44 |
2 |
| Givaudan SA | 1948 |
2 |
| Insmed Incorporated | 263 |
2 |
| KEMET Electronics Corporation | 325 |
2 |
| Melinta Therapeutics, Inc. | 48 |
2 |
| Other owners | 121 |